Keywords: sales, fall, profits, rise, ares-serono, switzerland-based, reported
Sales Fall But Profits Rise At Ares-Serono
Article | 16 April 1998
Switzerland-based Ares-Serono has reported net sales of $193.8 millionfor the first quarter of 1998, a fall of 8.6% (or 3.2% in local currencies) compared ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
